Innovation Pharmaceuticals Inc (IPIX)

[BioTechMaven]

My take is the interim was SO good, but a small population. Also, severe chemo patients are a difficult subject group (ie anything can happen that is in gods hands). My take alone is: a trial pass (not fail) with a clear and evident spread between the arms (ie that clearly shows the drug works and has helped a high enough percentage of the population to be meaningful)—and in this case you can draw comps from other om trials. Worth noting how HiGH of a bar ipix set in trial design: prevention and duration—almost unheard of by other pharmas confronting. Ipix has big balls. I’m on the edge of my seat to see how the trial unfolds.